In This Section      
Print This Page

Advancements in Research

Researchers at Johns Hopkins are constantly advancing science through basic, translational and clinical investigations. Here are highlights of our most current findings.

Fundamentals

brainmusic

Drug's Approval Marks a Milestone in Personalized Cancer Treatment

The FDA approval of a drug targeting disease genetics rather than type marked the first official recognition of what research at Johns Hopkins and elsewhere has long suggested would be an effective strategy. Now a reality, the drug can help 1 in 25 advanced cancer patients who otherwise would have little hope of treatment.

Read more

Science: Out of the Box

Understanding Ubiquitin

Johns Hopkins biophysicist Cynthia Wolberger explains how the small protein ubiquitin regulates many events in the cell, including turning genes off and on.

Epigenetics: A Symphony of Discovery

Johns Hopkins Kimmel Cancer Center Director, Bill Nelson, M.D., Ph.D., discusses epigenetics using musicians from the Peabody Institute.

Latest in Research

group of antibiotic pills

One in five patients prescribed antibiotics experience side effects

A new study on hospitalized adults adds to growing evidence that antibiotics are not benign and that clinicians often fail to weigh both the risks and benefits of antibiotics before prescribing them.

Read more